-
1 Comment
Henan Taloph Pharmaceutical Stock Co.,Ltd is currently in a long term uptrend where the price is trading 2.7% above its 200 day moving average.
From a valuation standpoint, the stock is 77.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Henan Taloph Pharmaceutical Stock Co.,Ltd's total revenue rose by 7.5% to $317M since the same quarter in the previous year.
Its net income has dropped by 80.3% to $1M since the same quarter in the previous year.
Finally, its free cash flow grew by 37.1% to $-22M since the same quarter in the previous year.
Based on the above factors, Henan Taloph Pharmaceutical Stock Co.,Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| CurrencyCode | CNY |
| ISIN | CNE0000010L8 |
| Exchange | SHG |
| Market Cap | 3B |
|---|---|
| PE Ratio | 88.83 |
| Target Price | None |
| Beta | 0.91 |
| Dividend Yield | None |
Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Danshen oral liquid, pediatric heat-clearing and cough-relieving oral liquid, pediatric compound chicken gizzard chewable tablets, and Huperzine A tablets. The company serves hospitals, primary medical institutions, and retail terminals. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. Henan Taloph Pharmaceutical Stock Co.,Ltd was founded in 1993 and is based in Zhengzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600222.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
